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Alternatively Activated Macrophages Elicited by Helminth
Infection Can Be Reprogrammed to Enable Microbial Killing1
Katie J. Mylonas,2 Meera G. Nair,2,3 Lidia Prieto-Lafuente, Daniel Paape, and Judith E. Allen4
The prime function of classically activated macrophages (activated by Th1-type signals, such as IFN-) is microbial de-
struction. Alternatively activated macrophages (activated by Th2 cytokines, such as IL-4 and IL-13) play important roles in
allergy and responses to helminth infection. We utilize a murine model of filarial infection, in which adult nematodes are
surgically implanted into the peritoneal cavity of mice, as an in vivo source of alternatively activated macrophages. At 3 wk
postinfection, the peritoneal exudate cell population is dominated by macrophages, termed nematode-elicited macrophages
(NeM), that display IL-4-dependent features such as the expression of arginase 1, RELM- (resistin-like molecule ), and
Ym1. Since increasing evidence suggests that macrophages show functional adaptivity, the response of NeM to proinflam-
matory Th1-activating signals was investigated to determine whether a switch between alternative and classical activation
could occur in macrophages differentiated in an in vivo infection setting. Despite the long-term exposure to Th2 cytokines
and antiinflammatory signals in vivo, we found that NeM were not terminally differentiated but could develop a more
classically activated phenotype in response to LPS and IFN-. This was reflected by a switch in the enzymatic pathway for
arginine metabolism from arginase to inducible NO synthase and the reduced expression of RELM- and Ym1. Further-
more, this enabled NeM to become antimicrobial, as LPS/IFN--treated NeM produced NO that mediated killing of
Leishmania mexicana. However, the adaptation to antimicrobial function did not extend to key regulatory pathways, such as
IL-12 production, which remained unaltered. The Journal of Immunology, 2009, 182: 3084 –3094.
S ignals encountered by developing macrophages (M)5during migration determine their functional properties atsites of inflammation or infection. Among these signals,
cytokines, which can act synergistically or have opposing effects,
are responsible for the development of highly divergent M phe-
notypes. Classical activation of M is dependent on the products
of activated Th1 cells, in particular IFN- (1). The prime function
of classically activated M (CAM) is microbial destruction,
which is conducted by the production of reactive oxygen and ni-
trogen intermediates such as NO from inducible NO synthase
(iNOS/NOSII) (2). Alternatively activated M (AAM), activated
by the Th2 cytokines IL-4 and IL-13, play important roles in al-
lergy and responses to parasite infection (1). AAM and CAM
exhibit distinct L-arginine metabolism pathways. CAM produce
NO as a result of the up-regulation of iNOS, which is a catalyst of
the L-arginine substrate (3). In AAM, L-arginine is converted to
L-ornithine and urea by the enzyme arginase 1 (3). The induction
of either arginase or iNOS is usually coupled with suppression of
the opposing enzyme (4). While the NO produced by CAM has
antimicrobial and cytotoxic properties, L-ornithine produced by
AAM can be further metabolized to proline and polyamines,
which have roles in collagen production and cell proliferation, re-
spectively. These properties have led to the hypothesis that AAM
are involved in wound healing (5, 6).
Although M have been usefully classified in this way, the
range of actual phenotypes is likely to be much broader, with
AAM and CAM representing two points in a wide spectrum.
Unlike Th cells where activation leads to terminal differentiation
into Th1 and Th2 cells, M appear to display a high degree of
flexibility (7–10). Plasticity of function may be an economical
strategy for the immune system since, in contrast to the high turn-
over of T cells, M are longer lived and may need to adapt their
function to different pathogens or environments they will face dur-
ing their lifespan.
Many studies have shown that M responsiveness to a given
cytokine can be altered and/or suppressed by the cytokines to
which it was previously exposed (11, 12). However, the flexibility
of the AAM phenotype is still a subject of controversy. While
some reports show that IL-4 pretreatment of M renders them
unresponsive to Th1 activation (4, 11–14), others have found that
the previous IL-4 exposure enhanced the responsiveness to Th1-
activating signals (15). As these results were obtained by in vitro
activation with IL-4, the differences may be due to variation in the
length and intensity of the activation stimuli. Indeed, Stout et al.
demonstrated that two cytokines could have either antagonistic or
synergistic effects on murine M function dependent on the order
and length of each cytokine treatment (16). In another study, hu-
man M were stimulated with either pro- (e.g., TNF-) or anti-
inflammatory (e.g., IL-10) cytokines and then cultured with a
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counterstimulatory cytokine or medium alone, and it was found
that M stimulated toward a specific activation state could switch
their phenotype rapidly when given counterstimulatory signals or
return to a quiescent state after signal arrest (9). Due to conflicting
in vitro data, it is difficult to determine whether M demonstrate
functional adaptivity in vivo and to ascertain the physiological
relevance of this phenomenon. Investigating M plasticity in vivo
could have important implications for therapeutic targeting of M
in chronic diseases but also for our general understanding of how
the immune system copes with multiple infections that may require
differing immune responses. In support of the hypothesis that M
plasticity may confer increased efficiency and flexibility for the
immune response, Gratchev et al. demonstrated that in response to
a second stimulation with IFN-, in vitro-derived human AAM
displayed significantly higher bactericidal activity (17). Also, pre-
treatment of murine macrophages with the IL-13 was found to
enhance LPS-induced anti-Toxoplasma gondii activity (18). How-
ever, the degree of flexibility of M recruited to sites of infection
is still unknown.
In this study, we have used a murine model for filarial in-
fection as a source of M, which we have previously termed
nematode-elicited M (NeM) (19 –21). Mice are surgically
implanted i.p. with the adult stage of the nematode Brugia ma-
layi. By 1 wk postinfection, the peritoneal exudate cell (PEC)
population is dominated by M that display IL-4-dependent
features such as the expression of arginase 1, RELM- (resis-
tin-like molecule ), and Ym1, as well as the ability to suppress
the proliferation of neighboring cells (19, 22). This phenotype
is sustained for many weeks in vivo. We have previously shown
that NeM share many properties with M differentiated in
vitro in response to IL-4 or IL-13 (hereafter termed in vitro
AAM) (19). However, NeM are recruited during a chronic
Th2-dominated nematode infection and experience much longer
term exposure to IL-4 and IL-13 than in vitro-AAM. Further-
more, NeM are influenced by parasite-secreted products as
well as host factors other than IL-4, such as IL-10 and glu-
cocorticoids. In light of the increasing evidence that M show
functional adaptivity, we decided to study the NeM response
to Th1-activating signals as a model to investigate whether M
differentiated in a chronic Th2 infection setting could alter their
established phenotype and whether this would translate into an
ability to control an intracellular microbial infection.
Despite the long-term exposure to Th2 cytokines and antiin-
flammatory signals in vivo, we found that NeM were still
responsive to LPS and IFN-, exhibiting dramatic changes in
gene expression profile. Additionally, LPS/IFN- treated NeM
were able to effectively control infection with Leishmania mexi-
cana. However, LPS/IFN- treated NeM still maintained the
IL-4-dependent capacity to suppress proliferation and failed to
up-regulate IL-12. Taken together, these results demonstrate
that M differentiated in vivo can make radical alterations in
phenotype to accommodate a new challenge. However, func-
tional plasticity may be limited to effector rather than to regu-
latory pathways.
Materials and Methods
Mice and infection
Wild-type (WT) or IL-4/ mice on the C57BL/6 background were bred in
house or purchased from Harlan U.K. Mice were 6–8 wk old at the start
of the experiment, and all work was conducted in accordance with the
Animals (Scientific Procedures) Act of 1986. Adult B. malayi parasites
were removed from the peritoneal cavity of infected gerbils purchased
from TRS Laboratories or maintained in house. Mice were surgically im-
planted i.p. with five to six live adult female B. malayi. Three weeks later,
mice were euthanized and PECs harvested by washing of the peritoneal
cavity with 15 ml of ice-cold DMEM. As a control for non-Th2-polarized
inflammation, mice were injected i.p. with 0.8 ml of 4% thioglycollate
medium, brewer modified (BD Biosciences). Three days later, the PECs
were harvested, as above.
M activation
PECs were cultured in DMEM, supplemented with 10% FCS, 2 mM L-
glutamine, 0.25 U/ml penicillin, and 100 mg/ml streptomycin. Thioglycol-
late-elicited PECs were plated in 9-cm petri dishes and left untreated or
treated for 18–24 h with IL-4 (20 ng/ml; BD Pharmingen). Nonadherent
cells were subsequently washed off and the remaining adherent M were
left untreated or treated with LPS (100 ng/ml; Escherichia coli 0111:B4;
Sigma-Aldrich) and IFN- (10 U/ml; BD Pharmingen) together or sepa-
rately for 18–24 h. NeM were similarly recovered and plated in medium
alone or with LPS and/or IFN-. Following treatment, the nonadherent
cells were washed off and the adherent M were recovered by a 15-min
incubation at 37°C in warm 10 mM glucose and 3 mM EDTA in PBS. For
cell division analysis, cells were washed in PBS and then resuspended at
1  107/ml in 5 M CFSE in serum-free DMEM for 8 min at 37°C. The
reaction was quenched with an equal volume of FCS and cells were washed
several times in serum-free DMEM. Bone marrow-derived M (BMM)
were prepared by harvesting bone marrow from the femur and tibia of
C57BL/6 mice. Erythrocytes were lysed using 3 ml of RBC lysis buffer
(Sigma-Aldrich) for 5 min. Differentiation into M was performed accord-
ing to published protocols (23). Cells were plated onto Petri dishes at 7.5
106 cells/plate and cultured in DMEM, supplemented with 25% FCS (In-
vitrogen), 25% L929 supernatant as a source of M-CSF, 2 mM L-glu-
tamine, 0.25 U/ml penicillin, and 100 g/ml streptomycin. The medium
was replaced after 4–6 days to generate a pure population of M at day 7.
BMM were then plated in medium alone or with LPS and/or IFN- (as
above).
Flow cytometry
Cells were incubated at 4°C for 15 min in blocking buffer (2% mouse
serum, 10 g/ml anti-CD16/32 in FACS buffer (PBS supplemented with 2
mM EDTA and 0.5% BSA)), followed by staining for 20 min on ice with
the Abs of interest at the appropriate dilution as determined by titration.
Abs included tricolor-conjugated anti-F4/80 (Caltag Laboratories), PE-
conjugated anti-B7.1/B7.2/MHC class II (BD Pharmingen), PE-conjugated
anti-programmed death ligand (PD-L)1/PD-L2 (eBioscience), as well as
appropriate isotype control Abs. Cells were washed three times in FACS
buffer and fixed in 0.8% paraformaldehyde before acquisition and analysis
(FACStation and FlowJo software; BD Biosciences).
Proliferation assay
M purified by adherence were cocultured (1  105 cells/well) in 96-well
flat-bottom plates with EL-4 cells (1 104/well) in the presence or absence
of the inhibitors NG-monomethyl-L-arginine (L-NMMA; 100 M; Sigma-
Aldrich) or N-hydroxy-nor-L-arginine (nor-NOHA; 250 M; Sigma-
Aldrich). After 48 h, 100 l of supernatant was removed to measure NO
production. For each well, 1 Ci of [3H]TdR was added and plates were
incubated overnight before harvesting and counting using a liquid scintil-
lation counter (MicroBeta 1450; TriLux). Quadruplicate measurements per
sample were performed. Results were plotted in cpm.
Quantification of NO production and arginase activity
NO production was assessed by nitrite accumulation in the culture media
using the Griess reagent. In brief, 100 l of culture supernatant was mixed
with 100 l of 5.8% phosphoric acid, 1% sulfanilamide, and 0.1% N-(1-
naphthyl)ethylenediamine dihydrochloride. Absorbance was measured at
490 nm with background correction at 650 nm using a microplate reader.
Concentration was determined according to a standard curve of sodium
nitrite solution. Arginase activity was measured according to previously
published protocols (3). Briefly, 1–2  105 cells were lysed with 100 l of
0.1% Triton X-100. Following a 30-min incubation with shaking, 100 l of
25 mM Tris-HCl (pH 7.2) and 20 l of 10 mM MnCl2 were added and the
enzyme was activated by heating to 56°C for 10 min. L-Arginine hydrolysis
was conducted by incubating 100 l of this lysate with 100 l of 0.5 M
L-arginine (pH 9.7) at 37°C for various time points between 15 and 60 min.
The reaction was then stopped with 800 l of H2SO4 (96%)/H3PO4 (85%)/
H2O (1/3/7, v/v/v), and 40 l of 9% isonitrosopropiophenone was added,
followed by heating to 99°C for 30 min before reading on the microplate
reader at 540 nm. A standard curve of urea solution was used to determine
concentrations. One unit of arginase enzyme activity is defined as the
amount of enzyme that catalyzed the formation of 1 mol of urea per
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minute at 37°C. Unless otherwise stated, all reagents were obtained from
Sigma-Aldrich.
RNA extraction and real-time RT-PCR
RNA was recovered from cells by resuspension in TRIzol reagent (In-
vitrogen). Total RNA was extracted according to the manufacturer’s
instructions. Following DNAse1 treatment (Ambion), 1 g of RNA was
used for the synthesis of cDNA using Moloney murine leukemia virus
reverse transcriptase (Stratagene). Relative quantification of the genes of
interest was measured by real-time PCR, using the Roche LightCycler.
PCR amplification conditions and primers have been described previ-
ously (20). Five serial 1/4 dilutions of a positive control sample of
cDNA were used as a standard curve in each reaction, and the expres-
sion levels were estimated from the curve. Real-time PCR of the house-
keeping gene -actin allowed normalization of the expression of the
genes of interest.
Cytokine quantification
For measurement of cytokine production, 5  105 PECs were plated in
24-well plates for 2– 4 h followed by removal of nonadherent cells. The
remaining adherent M were left untreated or were treated for 24 h with
LPS/IFN- as described above, followed by recovery of the superna-
tants for cytokine quantification. TNF- was measured using the Duo-
Set TNF- ELISA kit (R&D Systems) according to the manufacturer’s
instructions. IL-6 and IL-12p40 were measured according to standard
sandwich ELISA protocols, using Ab pairs (unconjugated and biotin-
ylated) from BD Pharmingen, and ExtrAvidin-alkaline phosphatase
conjugate in conjunction with SigmaFast p-nitrophenyl phosphate tab-
let substrate (both from Sigma-Aldrich). IL-10 and MCP-1 were quan-
tified using the cytokine bead array (CBA) kit (BD Pharmingen) ac-
cording to the manufacturer’s instructions.
M infection with L. mexicana
L. mexicana (strain MNYC/BZ/62/M379 or MNYC/BZ/62/M379 with
DsRed integrated into sRNA locus) (24) promastigotes were cultured in
vitro in semidefined medium (25) with 10% FCS and 1% penicillin-
streptomycin (complete semidefined medium) at 26°C. Promastigotes
were added to M, purified by adherence, and plated on coverslips
(BDH Laboratory Supplies) in 24-well plates, at a ratio of 10:1 for 3 h
or 30:1 for 3 h, in the case of the red strain. The M were then washed
twice with complete DMEM to remove nonphagocytosed parasites and
wells were replenished with complete medium. Where indicated, the
NO inhibitor L-NMMA was added to a final concentration of 400 M.
At day 3 postinfection, cells were fixed with 2% formaldehyde for 20
min at room temperature, washed twice with PBS, and stained with
0.5–1 ml of Giemsa for 5–10 min, followed by two washes with dis-
tilled H2O. Coverslips were removed from wells, allowed to dry, and
mounted onto slides with DPX mount (BDH Laboratory Supplies) be-
fore microscopic examination. Approximately 200 cells per group were
counted and the percentage infection was recorded. Unless otherwise
stated, all reagents were obtained from Sigma-Aldrich. Alternatively, a
leishmanicidal assay was conducted at 3 h postinfection as previously
described (26). The cells were lysed using 0.01% SDS in 100 l of
DMEM (FCS free) for 30 min and pipetted up and down 5–10 times.
Released amastigotes were resuspended in complete semidefined me-
dium in a total of 600 l per well and cultured for 72 h at 26°C. Four
aliquots of 150 l for each sample were then transferred to quadrupli-
cate wells of a 96-well plate and pulsed with [methyl-3H]thymidine (1
Ci/well) for a further 18 h at 26°C, and incorporation was assessed on
a liquid scintillation counter (MictoBeta 1450; TriLux). Leismanicidal
activity was measured as reduction in the incorporation of [3H]thymi-
dine by surviving parasites. Unless otherwise stated, all reagents were
obtained from Sigma-Aldrich. For immunofluorescence assays, M in-
fected on coverslips were fixed in 1–2 ml of 3% paraformaldehyde (in
PBS) for 20 min and then washed in PBS. They were permeabilized in
1–2 ml of 0.25% Triton X-100 (in PBS) for 10 min and washed in PBS
again. Blocking for 30 min was conducted with 1–2 ml of 1–3% (w/v)
BSA in PBS. The primary Ab, anti-Ym1 (StemCell Technologies; 1/25
dilution in BSA/PBS) was incubated for 1 h. Coverslips were washed
three times in PBS for 5 min with shaking. The secondary Ab (anti-
rabbit Alexa Fluor 488 (Molecular Probes); 1/200 in BSA/PBS) was
incubated for 1 h and then cells were washed in PBS. For nuclear
staining, 1 l of 10 mg/ml 4,6-diamidino-2-phenylindole was added
during the first wash and then cells washed three more times for 5 min
with shaking. Coverslips were washed in dH2O and placed on top of
gel/mount on slides and allowed to dry in the dark. Cells were visual-
ized using an Olympus BX50 microscope, and images were taken with
a MicroColor RGB-MS-C camera.
Results
LPS/IFN- causes a switch in L-arginine metabolism from
arginase to iNOS and down-regulates the expression of
alternative activation markers
Preferential expression of arginase over iNOS is a consistent
feature of NeM (19). We decided to investigate whether the
Th1-activating signals (LPS and/or IFN-) could alter the
NeM iNOS/arginase balance. Thioglycollate-elicted M (ThioM)
and NeM were left untreated or were treated overnight with
LPS and/or IFN- and recovered for gene expression analysis
by real-time RT-PCR (Fig. 1, A and B). As expected, untreated
NeM showed high arginase 1 expression but low iNOS RNA
levels, while untreated ThioM showed none or low expression
of both genes. Both IFN- and LPS could act alone or in concert
to reduce the arginase 1 expression in NeM. This decrease was
paralleled by an increase in iNOS expression. In contrast,
ThioM required both signals for the induction of iNOS. This
could reflect the less mature activation state of this M type
(27), which may require signaling through a pathogen recogni-
tion receptor such as TLR4 before becoming responsive to
IFN-. For subsequent experiments we decided to use LPS and
IFN- together to ensure classical activation of the ThioM
group.
Although ThioM exhibited increases in arginase 1 mRNA in
response to LPS/IFN-, consistent with previous studies (3), this
induction in gene expression did not result in increased arginase
enzyme activity (Fig. 1C). Arginase and iNOS enzyme activities of
NeM were altered by LPS/IFN- and, although not as fully, they
did reflect the gene expression data (Fig. 1, C and D). This in-
cluded a down-regulation in arginase activity in LPS/IFN--
treated NeM and an increase in NO production. In contrast to the
mRNA levels, the NO produced by LPS/IFN--treated NeM was
lower than by LPS/IFN--treated ThioM. These differences may
reflect timing, as mRNA levels precede protein production, or
other posttranslational controls. For example, the higher level of
arginase in LPS/IFN--treated NeM may compete with iNOS for
L-arginine. Nevertheless, the increase in NO production coupled
by a decrease in arginase activity demonstrates that NeM can
alter the balance of arginine metabolism in response to proinflam-
matory signals.
Having identified RELM- and Ym1 as the main IL-4-depen-
dent genes expressed in NeM (19), we investigated whether
RELM-/Ym1 expression was also altered by LPS/IFN- treat-
ment. As a control for nondifferentiated M, we measured
RELM- and Ym1 expression in ThioM (Fig. 1E). We observed
induction of both genes by LPS/IFN- in a similar pattern to ar-
ginase 1 expression, although the expression levels were lower
than in untreated NeM. Upon overnight treatment with LPS/
IFN-, RELM- and Ym1 expression in NeM was reduced by up
to 90% (Fig. 1E). Subsequent experiments always demonstrated
reduced expression of these markers following LPS/IFN- treat-
ment but the extent of this reduction was variable, ranging from
30% to 90% (data not shown).
LPS/IFN--induced activation switch is not due to the
outgrowth of a minority cell population
To rule out the possibility that the phenotypic changes in LPS/
IFN--treated NeM represented an outgrowth of a naive M
population rather than a change in the existing NeM population,
we monitored the cell proliferation following treatment. Before
overnight treatment with LPS/IFN-, cells were labeled with
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CFSE and then recovered and analyzed by flow cytometry. This
allowed the comparison of proliferation between untreated and
LPS/IFN--treated M, as identified according to side scatter and
F4/80 expression (Fig. 2A). Following overnight treatment with
LPS/IFN-, ThioM and NeM groups did not undergo any cell
divisions and remained CFSEhigh. Thus, the switch in gene expres-
sion and iNOS/arginase activity represents a nondividing NeM
population and not the outgrowth of another cell population. Ad-
ditionally, fluorescent staining for Ym1 and RELM- by immu-
nofluorescence assay (see below) or intracellular FACS (data not
shown) suggested that this was a highly homogeneous starting
population with all F4/80 M expressing the alternative activa-
tion markers.
The mean fluorescence intensity (MFI) for F4/80 was higher
in NeM (176) than in ThioM (52) (Fig. 2B). Since F4/80 has
been implicated in immunological tolerance through the gener-
ation of regulatory T cells (28), the higher surface expression on
NeM may point to a regulatory function. M are a prominent
cell type in other filarial nematode infection models such as
Litomosoides sigmodontis, where regulatory T cells play an im-
portant role in immunoregulation (21, 29). Interestingly, LPS/
IFN- treatment affected F4/80 surface staining intensity, and
we observed a reduction in MFI in NeM (from 176 to 113) but
not in ThioM (from 52 to 58). Down-regulation in F4/80 ex-
pression upon Th1 activation could have an impact on the reg-
ulatory properties of NeM.
Suppressive phenotype of NeM is not altered by LPS/IFN-
Since proliferative suppression is one of the well-defined reg-
ulatory properties of NeM (22, 30), we decided to investigate
whether LPS/IFN- affected the ability of NeM to suppress
the proliferation of cocultured EL-4 thymoma cells. We in-
cluded the NO inhibitor L-NMMA as a control since LPS/IFN-
treatment resulted in NO production from all M groups (see
Fig. 1), and we wanted to distinguish the known suppressive
effects of NO (31–33) from the suppressive mechanism medi-
ated by NeM. Having previously shown that the NeM sup-
pressive phenotype is dependent on IL-4 (22), we also included
NeM generated in IL-4-deficient mice as a negative control
for proliferative suppression. Finally, we included ThioM pre-
treated with IL-4, allowing a comparison between in vitro-de-
rived AAM and in vivo-derived NeM.
As expected, the EL-4 cell proliferation was suppressed when
cocultured with NeM in comparison to control ThioM (Fig. 3A,
FIGURE 1. LPS/IFN- reduce alternative activation
of NeM and enhance iNOS activity. ThioM or
NeM from C57BL/6 mice were left untreated or
treated overnight with LPS and/or IFN- as indicated.
The cells were recovered for RNA expression analysis
of arginase 1 (A), iNOS (B), RELM-, and Ym1 (E) by
real-time RT-PCR and assessed for arginase activity
(C). The supernatants were also recovered to assess the
iNOS activity by measurement of nitrite production by
the cells (D). Results are shown as the means of repli-
cate samples (SEM) and are representative of three
independent experiments.
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open bars). ThioM pretreated with IL-4 (in vitro AAM) were
equally suppressive while IL-4/ NeM were unable to suppress
EL-4 proliferation, confirming that IL-4 was essential for the de-
velopment of this suppressive phenotype. When treated with LPS/
IFN- (black bars), all M cell types could suppress proliferation.
However, L-NMMA treatment (gray bars) reversed the LPS/IFN-
-induced suppressive phenotype in the ThioM and the IL-4/
NeM, demonstrating that this suppression was NO mediated. In
response to LPS/IFN- treatment, NeM and in vitro AAM still
suppressed EL-4 thymoma proliferation but this was not NO me-
diated, as it was not altered by L-NMMA. LPS/IFN- is thus not
sufficient to reverse the suppressive function of either in vitro- or
in vivo-derived AAM.
While all M groups produced NO in response to LPS/IFN-,
NeM produced less NO than did ThioM (Fig. 3B), consistent
with our previous data (Fig. 1D). Of note, WT NeM showed
increased responsiveness to LPS/IFN- in comparison to IL-4/
NeM and produced higher levels of NO. This implies that acti-
vation by IL-4 may in fact enhance responsiveness to classical
activation stimuli as previously reported (15, 16).
The IL-4-dependent mechanism of proliferative suppression is
still unknown but one possibility is that arginase acts by depleting
arginine needed for cell growth (34). To test this possibility, WT
NeM were treated with nor-NOHA to inhibit arginase 1 activity.
This led to partial reversal of the suppressive phenotype, with nor-
NOHA treatment enhancing proliferation of the EL-4 cells cocul-
tured with NeM (Fig. 3C). However, EL-4 cells cocultured with
nor-NOHA-treated ThioM also exhibited dramatically enhanced
proliferation. This suggests that inhibition of even constitutive lev-
els of arginase has significant effects on cellular proliferation. In
the presence of nor-NOHA, NeM permitted only one-fifth the
level of EL-4 proliferation as similarly treated ThioM, suggesting
that arginine consumption is not the dominant mechanism of sup-
pression in NeM.
NeM express cell surface activation markers that can be
further up-regulated in response to LPS/IFN-
We studied the surface expression of MHC class II and costimu-
latory molecules B7.1 and B7.2 to determine the activation status
of NeM before and after LPS/IFN- treatment (Fig. 4A). Un-
treated NeM expressed higher levels of MHC class II, B7.1, and
B7.2 than did ThioM, as shown by MFI. The high expression of
these markers is consistent with the original classification of
AAM as “activated” (35) and the data that ThioM are relatively
“inactive” (27). It is also consistent with previous studies showing
that NeM are efficient APCs (36). Upon LPS/IFN- stimulation,
the MFI of all markers was increased in both ThioM and NeM,
FIGURE 2. M do not divide in response to LPS/IFN- but down-regulate F4/80. C57BL/6 mice were implanted i.p. with B. malayi adult worms and
the PECs were recovered 3 wk later. For comparison, C57BL/6 mice were injected i.p. with thioglycollate and the ThioM were recovered at day 3. A,
The cells were labeled with CFSE and left untreated or treated with LPS/IFN- overnight followed by flow cytometry analysis to identify the M population
by F4/80 and side scatter and to monitor cell division according to the dilution of CFSE. B, The surface intensity of F4/80 in ThioM and NeM was also
monitored for changes in response to LPS/IFN- treatment. Numbers in the legend represent MFI.
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and the MFI for MHC class II and B7.2 was highest in LPS/IFN-
treated NeM.
PD-L1 and PD-L2 are members of the B7 family of costimula-
tory molecules and have been reported as useful markers to dis-
tinguish between classical and alternative activation of M in vitro
(37). Additionally, they have been implicated in the proliferative
suppression observed by M during infection with the platyhel-
minths Taenia crassiceps and Schistosoma mansoni (38, 39). We
thus measured surface expression of both PD-L1 and PD-L2 in
NeM (Fig. 4B). PD-L1 surface expression was similar in both
ThioM and NeM and was up-regulated in both M groups in
response to LPS/IFN-, consistent with reports that classically ac-
tivated M show increased PD-L1 expression (37). Surprisingly,
despite previous studies reporting PD-L2 as a marker for in vitro
AAM (37), neither untreated or LPS/IFN--treated NeM ex-
pressed PD-L2. To confirm that the PD-L2 staining was optimal,
we demonstrated that in vitro IL-4 treatment could up-regulate
PD-L2 on ThioM (Fig. 4B) as previously shown (37). Our find-
ing that in vivo AAM display different surface expression pro-
files to in vitro-derived AAM is consistent with previous studies
that reported differences in gene expression profiles and cell mor-
phology (40), and it reiterates the importance of in vivo models for
the study of these activated M subsets. Furthermore, in contrast
to suppressive M found in platyhelminth infection (38, 39), these
data suggest that the PD-L1/PD-L2 costimulatory molecules may
not be responsible for the suppression we observe in nematode
infection.
TNF-, IL-6, and IL-10, but not IL-12p40, production is
enhanced in response to LPS/IFN-
ThioM, in vitro AAM, and NeM were again left untreated or
were treated overnight with LPS/IFN- and then supernatants were
taken for cytokine measurement by sandwich ELISA or CBA. Fig.
5 shows that TNF- was absent in all groups but was induced in
response to LPS/IFN- in both ThioM and ThioM plus IL-4.
Although TNF- was induced to a much lesser extent in NeM
than in ThioM in the experiment shown, TNF is consistently
up-regulated in NeM by LPS/IFN- treatment and can some-
times exceed levels seen in similarly treated ThioM (data not
shown). Therefore, pretreatment with IL-4, or induction in an IL-4
environment, did not prevent TNF- from being induced by type
1 stimuli, consistent with previous reports from Stout et al. (16).
Untreated NeM produced high levels of IL-6 relative to ThioM,
and all groups displayed an increase in IL-6 expression with LPS/
IFN- treatment (Fig. 5).
Enhancement of TNF- and IL-6 together provided more evi-
dence that NeM can be reprogrammed to increase their proin-
flammatory capacity. However, the switch to a more classical
activation state was not complete. Whereas ThioM and in vitro-
derived AAM produced IL-12p40 in response to LPS/IFN-,
NeM completely failed to do so (Fig. 5). Consistent with previ-
ous reports that IL-10 is produced by AAM (41), IL-10 was
produced to the greatest extent by NeM and increased following
LPS/IFN- treatment.
LPS/IFN- enables NeM to control Leishmania infection
As LPS/IFN- treatment could induce alternatively activated
NeM to a produce NO and TNF, we asked whether this flex-
ibility was reflected in the functional ability to control infection
by an intracellular pathogen. To address this question, L. mexi-
cana promastigotes were used to infect untreated and LPS/IFN-
-stimulated NeM and BMM. Parasite survival after 3 h was
determined by lysis of the M and measurement of the parasite
proliferation by [3H]thymidine incorporation (Fig. 6). Un-
treated NeM had the most surviving promastigotes after 3 h.
This likely correlates with enhanced parasite uptake. The
NeM group recorded more than 10,000 cpm compared with
BMM with or without LPS/IFN-, which had less than one-
tenth the cpm (Fig. 6; 1000 cpm). NeM may have encountered
signals in vivo that increase expression of the receptors in-
volved in the phagocytosis of Leishmania (e.g., complement
receptors) (42). The thymidine count for NeM treated with
LPS/IFN- was 2500 cpm, which suggests that this group only
allowed uptake of approximately one-fourth the number of pro-
mastigotes, perhaps due to the absence or down-regulation of
these receptors (Fig. 6).
To assess the capacity of different M populations to control L.
mexicana growth, we determined the percentage of M infected
after 3 days by microscopy. Fig. 7A shows that LPS/IFN- treat-
ment, and to a lesser extent IFN- alone, conferred resistance to
FIGURE 3. NeM can produce NO in response to LPS/IFN- but will
still retain the ability to suppress cell proliferation in a NO-independent
manner. ThioM, ThioM  IL-4, NeM, and IL-4/ NeM were left
untreated or were treated with LPS/IFN- overnight followed by replace-
ment of the medium and coculture with EL-4 thymoma cells with or with-
out the NO inhibitor L-NMMA. After 48 h, the EL-4 cell proliferation was
assessed by [3H]thymidine incorporation (A) and supernatants were recov-
ered for measurement of the NO levels (B). Data are representative of three
separate experiments and are plotted as the means of triplicate wells
(SEM). In a separate experiment ThioM and NeM were treated with
the arginase inhibitor nor-NOHA. They were cocultured with EL-4 thy-
moma cells and again after 48 h the EL-4 cell proliferation was assessed by
[3H]thymidine incorporation (C). EL-4 cells cultured alone proliferated at
150,000 cpm (A) and 250,000 cpm (B).
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L. mexicana in both BMM and NeM. Indeed, NeM appeared
better able to clear infection when treated with IFN- alone than
did BMM.
In a separate experiment we examined the role of NO in the
leishmanicidal activity observed by NeM treated with LPS/
IFN-. L-NMMA was used to inhibit iNOS activity, as verified by
nitrite levels of the day 3 supernatant (Fig. 7B), and the M were
again examined after 3 days of infection (Fig. 7C). In agreement
with the previous experiment, LPS/IFN- treatment of NeM con-
ferred an increased ability to kill Leishmania, but in the presence
of iNOS inhibitors, NeM treated with LPS/IFN- were rendered
as susceptible to infection as those not treated (Fig. 7C). These
data demonstrate that NO is playing an important role in micro-
bicidal activity of LPS/IFN--activated NeM.
To visualize these results, experiments were also conducted with
promastigotes of a L. mexicana strain that displays red fluores-
cence (24). In these experiments ThioM were used as controls.
Fig. 7D shows that in the untreated groups there is an abundance
of red intracellular parasites at day 3, but in all LPS/IFN--treated
groups we saw an almost complete absence of L. mexicana. Thus,
FIGURE 4. Effect of LPS/IFN- on the cell surface activation markers in naive M and NeM. Untreated ThioM, IL-4-treated ThioM (tinted), or
NeM were left untreated or treated overnight with LPS/IFN-. The cells were recovered and double-stained for F4/80 and MHC class II, B7.1, B7.2 (A)
or PD-L1 and PD-L2 (B). Flow cytometry graphs show histograms of F4/80-gated M, and dashed lines show the isotype control. MFI of histograms for
untreated or treated M are displayed. Results are representative of three experiments.
FIGURE 5. TNF-, IL-6, and IL-10, but not IL-12p40, production is
enhanced in response to LPS/IFN-. ThioM, ThioM IL-4, and NeM
were untreated (open bars) or were treated overnight with LPS/IFN-
(filled bars). Supernatants were recovered and the levels of various cyto-
kines were measured by sandwich ELISA (TNF-, IL-6, and IL-12p40) or
CBA (IL-10). Results are shown as the mean of replicate samples (SEM)
and are representative of three experiments.
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these type 1 stimuli again conferred full resistance to this intra-
cellular parasite, regardless of M history. These results were con-
firmed by microscopic examination (Fig. 7E). M were also
stained with anti-Ym1 to confirm their AAM status before in-
fection. To our surprise, Ym1 staining was still detectable follow-
ing LPS/IFN- treatment (Fig. 7D, green). As this contrasted with
our previous data in which Ym1 mRNA decreases upon LPS/IFN-
treatment (Fig. 1E), we chose to repeat these experiments to mea-
sure both protein and RNA simultaneously. The finding confirmed
those in Figs. 1E and 7D by demonstrating that while mRNA lev-
els decrease in response to LPS/IFN-, protein is still detectable
(data not shown).
Discussion
M can be involved in both pro- and antiinflammatory responses,
in tissue destructive activities as well as in restorative activities (1,
43). Increasing evidence suggests that M activated in a Th2 set-
ting have tissue repair as a primary function. This hypothesis has
been driven by the knowledge that proline, which is an important
precursor of collagen and polyamines that are involved in cell
proliferation, is produced by AAM under the control of arginase
(5) and is supported by subsequent data that AAM are involved
in fibrosis (6). Recent data from our laboratory strongly support
this hypothesis, as the key features of alternative activation are
induced solely in response to tissue injury (20, 44). It is under-
standable that a strong wound healing response would occur in the
context of helminth infection, as tissue migratory or tissue invasive
parasites often lead to physical trauma to host tissue. Importantly,
the entire process of tissue repair requires the production of anti-
inflammatory factors (45). Consistent with this, NeM produce
many factors associated with tissue repair and reduced inflamma-
tion (e.g., arginase 1, IL-10 (Figs. 1A and 5, respectively) and
TGF- (data not shown)) (46, 47). We wanted to determine if the
immune system, faced with a potentially more life-threatening sit-
uation (i.e., a bacterial pathogen), had the capacity to rapidly
switch from a wound healing to a proinflammatory response. Such
functional plasticity would allow AAM involved in a tissue re-
pair to respond appropriately to a microbial challenge, and this
would be beneficial before the recruitment of new cells to the site
of dual infection.
We show herein that a M population generated in the Th2
environment of helminth infection in vivo can respond to proin-
flammatory stimuli ex vivo. Following overnight incubation of
NeM with IFN- and LPS, there was reduced expression of tran-
scripts for the alternative activation markers arginase, RELM-,
and Ym1. This reduction was accompanied by a dramatic up-reg-
ulation of iNOS mRNA. Enzyme activity changes were also seen
but to a lesser degree than in control macrophages. Nonetheless,
the amount of NO produced was sufficient to fully control infection
FIGURE 6. Untreated NeM take up the most L. mexicana parasites.
BMM and NeM were untreated (open bar) or were treated overnight
with LPS/IFN- (filled bar) followed by infection with L. mexicana at 10:1
parasite/M ratio. Parasites that were not taken up were washed off 3 h
postinfection, and parasite uptake was determined by lysis of the M and
measurement of the parasite proliferation by [3H]thymidine incorporation.
Results are shown as the means of replicate samples (SEM) and are
representative of three experiments.
FIGURE 7. LPS/IFN- or IFN- alone confers resis-
tance of NeM to L. mexicana infection at day 3 postin-
fection. BMM and NeM were untreated (open bars)
or treated overnight with IFN- (gray bars) or LPS/
IFN- (black bars). The NO inhibitor L-NMMA was
also added (B and C). Infection with L. mexicana was at
a 10:1 parasite/M ratio. Parasite levels after 3 days
were measured by microscopic examination of the num-
ber of infected M (100–200 M counted per group) (A
and C). The supernatants were recovered for measure-
ment of the NO levels (B). In another experiment,
ThioM, ThioM IL-4, and NeM were treated as
before followed by a 30:1 infection ratio. Immunoflu-
oresence assays were conducted using a L. mexicana
strain that displayed red fluorescence, along with Ym-1
staining (green) (D). Parasite levels after 3 days were
again measured by Giemsa examination (E). Results are
representative of three experiments.
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with an intracellular pathogen, suggesting that NeM can divert
their resources toward antimicrobial activity if needed. We also
observed an increase in surface expression of class II and costimu-
latory molecules (Fig. 4A) under the influence of LPS/IFN-. This
suggests that these AAM have enhanced APC function. How-
ever, analysis of the NeM cytokine profile (Fig. 5) presented an
intriguing picture with implications for APC function. Although
LPS/IFN- treatment appeared to promote a more classically ac-
tivated phenotype in the AAM through elevated TNF-, IL-6,
and NO production, this switch was not complete, and they failed
to produce any detectable IL-12p40 (Fig. 5). Thus, although these
cells had enhanced antimicrobial killing and increased markers of
classical activation, they would not induce Th1 cell development
(48). Consistent with this, LPS/IFN- treatment caused the up-
regulation of IL-10 in NeM (Fig. 5), which inhibits Th1 cell
responses (49). Lamina propria M from the intestine of mice,
which like NeM express relatively high IL-10 and TGF-, also
produce little or no IL-12 after stimulation with TLR ligands (50).
Although the authors concluded that the IL-10-producing M are
hyporesponsive to TLR ligands, only IL-12 was assessed, and thus
it is possible that the defect, as in this study, was specific for IL-12.
Consistent with a specific defect in LPS-mediated IL-12 pro-
duction but not NO production, recent work from Foster et al. has
shown that TLR-induced genes with different functions may have
diverse regulatory requirements (51). On an epigenetic level, gene-
specific modifications of chromatin can lead to the priming of an-
timicrobial effectors while proinflammatory mediators, such as
IL-6, are silenced. This would potentially allow the immune sys-
tem to effectively deal with microbial pathogens while controlling
the pathology associated with inflammation (51). The fact that we
have seen the products of some genes associated with an antimi-
crobial response up-regulated in response to LPS/IFN- in NeM
(i.e., iNOS) but not to IL-12 suggests that these AAM may have
undergone similar epigenetic modifications in vivo. Indeed, a re-
cent study by Wen et al. has shown that dendritic cells recovered
from mice that have survived severe peritonitis-induced sepsis dis-
play a chronic suppression of IL-12 expression. The IL-12 defi-
ciency of dendritic cells from this setting is due to histone modi-
fication (52). Similarly, the propensity of NeM to produce large
amounts of IL-10 following LPS/IFN- stimulation may reflect
chromatin modifications to the IL-10 promoter locus, as shown for
superinduction of IL-10 by immune complexes (53).
We have shown that LPS/IFN- treatment could confer resis-
tance of NeM to infection with L. mexicana promastigotes. Mod-
els of murine Leishmania spp. involve a dominant Th1 response
leading to the classical activation of M and elimination of the
parasites through the production of NO (54). NeM were able to
control infection almost as well as BMM given the same treat-
ment of LPS/IFN- (Fig. 7A). The ability of NeM given IFN-
alone to control parasite numbers more effectively than for BMM
may be explained by signals that NeM encounter in vivo causing
the up-regulation of the receptor for IFN-. Consistent with this
hypothesis, NeM produced more iNOS mRNA in response to
IFN- treatment than ThioM (Fig. 1B).
Previous work in the field has shown that alternative M acti-
vation can promote Leishmania growth (55, 56). This is because
L-ornithine synthesized from arginase 1 activity, which is largely
controlled by IL-4, can be used by the parasites to generate poly-
amines and to proliferate (56, 57). The role of IL-4 for promoting
susceptibility in nonhealing murine L. mexicana infections has
been demonstrated, since susceptible mice lacking IL-4 or STAT6
acquire a Th1 response and fail to develop lesions (58–60). Al-
though these above findings may seem at odds with the results
presented herein, IL-4 does not always promote susceptibility.
IL-4 has been shown to provide a strong stimulus for the killing of
intracellular amastigotes of L. major, as long as low concentrations
of IFN- are present (61). Similarly, pretreatment with IL-13 has
been shown to increase the ability of M to effectively deal with
the intracellular protozoan parasite T. gondii after LPS activation
(18), and this was found to be due to enhanced NO production
(62). We found that susceptibility of NeM to L. mexicana de-
creased dramatically when treated with even IFN- alone, as well
as with LPS/IFN- (Fig. 7A). Although NeM from our B. malayi
infection model produced lower levels of NO after LPS/IFN-
treatment than did ThioM (Fig. 1D) or IL-4 pretreated ThioM
(data not shown), they were still enough to confer resistance. Even
when NeM were infected at a 30:1 ratio of parasites/M, they
still managed to clear the parasite upon LPS/IFN- treatment (Fig.
7, D and E). Thus, despite extensive exposure to type 2 cytokines
in vivo, the NeM maintained an IFN--responsive phenotype that
allowed the manifestation of a fully antimicrobial phenotype. As
these experiments were performed ex vivo, they do not allow us to
conclude the full infection outcome in the context of a Th2-medi-
ated response that would be maintained in vivo. As such, the data
are not directly comparable to studies in which helminth infection
exacerbated leishmania infection (55, 63). Nonetheless, they do
allow us to dissect the potential for functional adaptation of in
vivo-generated AAM.
A consistent feature of NeM and other helminth-induced M
is that they act as potent suppressors of cellular proliferation (22,
64), and several different mechanisms for the suppression have
been proposed. We recently provided evidence that TGF- may be
involved to some degree (21) and have now seen that arginase
contributes to this suppression since inhibition with nor-NOHA
caused a partial reversal of this phenotype. However, both arginase
(Fig. 1, A and C) and TGF- (data not shown) production were
partially reversed upon treatment with LPS/IFN-, and yet these
cells retained full suppressive abilities (Fig. 3A), so additional fac-
tors must be involved. PD-L1 has been implicated in the prolifer-
ative suppression observed by M during infection with the platy-
helminths T. crassiceps and S. mansoni (38, 39) and would be
consistent with a contact-dependent mechanism (22). However, we
did not find evidence for up-regulation of PD-L1 on NeM com-
pared with the ThioM controls (Fig. 4B). Also, NeM did not
up-regulate another marker of AAM generated in vitro, PD-L2
(Fig. 4B). Data now emerging from several laboratoties would sug-
gest that the profound suppression observed may be due to mul-
tiple antiproliferative mechanisms that in addition to PD-L inter-
actions (38, 39) include TGF- production (21) lipid mediator
release (65) and IL-10 production (66, 67).
We have shown that despite long-term exposure to Th2 cyto-
kines and antiinflammatory signals in vivo, M could respond to
the Th1-activating signals LPS/IFN- and become effectively an-
timicrobial. These ex vivo findings may not translate directly to in
vivo coinfection studies where cross-regulation will be occurring
at the level of the systemic T cell response as well as local effector
responses. However, they do provide evidence that M highly
polarized in vivo maintain remarkable phenotypic plasticity and
are very consistent with recent studies in which the abilities of
tumor-promoting AAM to become classically activated and pro-
mote tumor killing have been demonstrated (68, 69). Watkins et al.
demonstrated that systemic treatment of tumor-bearing mice with
IL-12 altered the functional response of M from a predominantly
antiinflammatory to a more proinflammatory phenotype, including
up-regulation of TNF- and IL-6. Importantly, these changes were
sustained over many days (70). These data support the viability of
therapeutic approaches to alter M polarization in vivo (71, 72).
Our data do not show that AAM make a complete conversion to
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CAM but rather that they adopt key aspects of the CAM phe-
notype necessary for a particular function, consistent with the par-
tially overlapping phenotypes observed during in vitro studies (9,
16, 17). Before the therapeutic potential can be fully realized a
much greater understanding of the mechanisms and limitations of
M plasticity are needed.
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